Risk-adapted induction and consolidation therapy in adults with de novo AML aged </= 60 years: results of a prospective multicenter trial

We treated 305 de novo acute myeloid leukemia (AML) patients aged

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of hematology 2004-06, Vol.83 (6), p.336-344
Hauptverfasser:	Heil, G, Krauter, J, Raghavachar, A, Bergmann, L, Hoelzer, D, Fiedler, W, Lübbert, M, Noens, L, Schlimok, G, Arnold, R, Kirchner, H, Ganser, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Amsacrine - administration & dosage Amsacrine - adverse effects Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - adverse effects Bone marrow Combined Modality Therapy Consolidation Cytarabine - administration & dosage Cytarabine - adverse effects Daunorubicin - administration & dosage Daunorubicin - adverse effects Etoposide - administration & dosage Etoposide - adverse effects Female Humans Idarubicin - administration & dosage Idarubicin - adverse effects Karyotyping Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - pathology Leukemia, Myeloid, Acute - therapy Male Medical research Middle Aged Prognosis Prospective Studies Remission Induction Risk Assessment Stem Cell Transplantation Survival Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	We treated 305 de novo acute myeloid leukemia (AML) patients aged
ISSN:	0939-5555 1432-0584
DOI:	10.1007/s00277-004-0853-z